EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Addressing the Blind Spots of Deaminase Base Editors with CRISPR-Cas Glycosylase-Based Editors

Jian Zhou iD

The CRISPR Journal · 01.12.2026 · 9 (5-6) · 241-253

DOI: 10.1177/25731599261475668 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The CRISPR Journal, online erschienen am 28.09.2026. Verfasst von Jian Zhou. Beteiligte Einrichtung: Department of Laboratory Medicines, The First Affiliated Hospital of Xi'an Medical University, Xian, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing, DNA Glycosylases. Die Arbeit nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of CRISPR base editors signifies a pivotal shift in genome editing, moving beyond the “cut-and-paste” approach into an era of precise “chemical rewriting.” While early editors including CBEs and ABEs enabled efficient base transitions by combining deaminases with Cas9 nickase, their core mechanism limited their application to transition mutations, leaving nearly half of disease-causing transversions unresolved. This review outlines the transformation of DNA glycosylases from unwanted side-effect generators into core drivers of base editor evolution. Through strategic protein engineering, glycosylases have been harnessed to create novel editors that mediate crucial transversion edits, substantially expanding the targeting landscape of precision genome editing. We will examine how these engineered glycosylases achieve programmable DNA rewriting through redirected DNA repair pathways, compare emerging and conventional editors, and explore applications in genetic therapy and functional genomics while addressing ongoing challenges in specificity and delivery. Finally, we envision next-generation editors equipped with artificial intelligence-designed glycosylases capable of spatiotemporally controlled genome manipulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsGene EditingDNA GlycosylasesHumansDNA RepairProtein Engineering

Substanzen

DNA Glycosylases

Autor:innen und Institutionen

  • Department of Laboratory Medicines, The First Affiliated Hospital of Xi'an Medical University, Xian, China.

ORCID-Profile: Jian Zhou

Zitieren

APA

Zhou, J. (2026). Addressing the Blind Spots of Deaminase Base Editors with CRISPR-Cas Glycosylase-Based Editors. The CRISPR Journal, 9(5-6), 241-253. https://doi.org/10.1177/25731599261475668

Vancouver

Zhou J. Addressing the Blind Spots of Deaminase Base Editors with CRISPR-Cas Glycosylase-Based Editors. The CRISPR Journal. 2026;9(5-6):241-253. doi:10.1177/25731599261475668

BibTeX
@article{Zhou2026,
  author = {Zhou, Jian},
  title = {Addressing the Blind Spots of Deaminase Base Editors with CRISPR-Cas Glycosylase-Based Editors},
  journal = {The CRISPR Journal},
  year = {2026},
  volume = {9},
  number = {5-6},
  pages = {241--253},
  doi = {10.1177/25731599261475668}
}
Kostenlos starten →